These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11714204)

  • 21. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders.
    Lewis C; Tesar GE; Dale R
    Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid-carbapenem interaction: report of six cases and a review of the literature.
    Tobin JK; Golightly LK; Kick SD; Jones MA
    Drug Metabol Drug Interact; 2009; 24(2-4):153-82. PubMed ID: 20408498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet counts, MPV and PDW in culture proven and probable neonatal sepsis and association of platelet counts with mortality rate.
    Ahmad MS; Waheed A
    J Coll Physicians Surg Pak; 2014 May; 24(5):340-4. PubMed ID: 24848393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR; Riela AR; Mills J; Browne R; Roach ES
    J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproic acid and immune thrombocytopenia.
    Barr RD; Copeland SA; Stockwell ML; Morris N; Kelton JC
    Arch Dis Child; 1982 Sep; 57(9):681-4. PubMed ID: 6812506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic lupus erythematosus associated with use of valproate.
    Asconapé JJ; Manning KR; Lancman ME
    Epilepsia; 1994; 35(1):162-3. PubMed ID: 8112240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible Valproic Acid-Induced Parkinsonism and Cognitive Impairment in an Elderly Patient With Bipolar Disorder I.
    Hassamal S; Waller S; Reese K; Testa C
    Turk Psikiyatri Derg; 2016; 27(3):213-217. PubMed ID: 27711942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk markers for thrombocytopenia in critically ill patients: a prospective analysis.
    Shalansky SJ; Verma AK; Levine M; Spinelli JJ; Dodek PM
    Pharmacotherapy; 2002 Jul; 22(7):803-13. PubMed ID: 12126213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?
    Akdeniz F; Taneli F; Noyan A; Yüncü Z; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):115-21. PubMed ID: 12551733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytopenia in the intensive care unit.
    Baughman RP; Lower EE; Flessa HC; Tollerud DJ
    Chest; 1993 Oct; 104(4):1243-7. PubMed ID: 8404200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet count and function in children receiving sodium valproate.
    Verrotti A; Greco R; Matera V; Altobelli E; Morgese G; Chiarelli F
    Pediatr Neurol; 1999 Sep; 21(3):611-4. PubMed ID: 10513686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.